SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-161972
Filing Date
2011-06-09
Accepted
2011-06-09 15:25:14
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 928581
2 LETTER AGREEMENT WITH WALTER C. HERLIHY dex1017.htm EX-10.17 8331
3 LETTER AGREEMENT WITH JAMES R. RUSCHE dex1018.htm EX-10.18 8320
4 LETTER AGREEMENT WITH DANIEL P. WITT dex1019.htm EX-10.19 8314
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2893
6 CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO SECTION 302 dex311.htm EX-31.1 6399
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 6369
8 CERTIFICATION OF CEO AND PRESIDENT AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 7420
9 GRAPHIC g195553g43f03.jpg GRAPHIC 66154
10 GRAPHIC g195553g67j56.jpg GRAPHIC 8084
  Complete submission text file 0001193125-11-161972.txt   1080252
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 11903126
SIC: 2836 Biological Products, (No Diagnostic Substances)